NanoMediTech said the funds will be used to support response efforts and medical equipment and supplies, sanitation equipment and precautionary measures incase if a second wave of the Coronavirus.
NanoMediTech’s Chief Science Officer, Mr. Laurent Brunet commented on the financial commitment saying "The COVID-19 pandemic is presenting a series of unprecedented challenges for people, governments and healthcare systems globally, which is why it is very important to immediately support local communities to contain the spread of the virus and help those directly impacted."
“We will be sending teams out to give advice and learning programs to help assist communities so we can educate them so that they have the knowledge and know what precautions to take. We hope is that this commitment will help other companies on the front lines address urgent needs as we begin to understand the long-term needs of our communities," added Laurent Brunet, Chief Science Officer of NanoMediTech.
About Us - NanoMediTech
Based in Seoul, Republic of Korea, NanoMediTech is a research and development company developing nanotechnology based biomedical applications. The company is leveraging its proprietary nanotechnologies to develop radically improved medical tools and solutions for the treatment of debilitating diseases and improvement of medical practices.
Nanotechnology is a burgeoning industry with practically limitless applications on our lives and with the potential to revolutionize the manner in which we detect and treat diseases and damage to the human body.